Working… Menu

A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01163565
Recruitment Status : Completed
First Posted : July 15, 2010
Last Update Posted : December 3, 2014
Medtronic - MITG
Information provided by (Responsible Party):
Todd McMullen, University of Alberta

Brief Summary:
This is a randomized, prospective equivalence trial on the safety of the Ligasure Vessel Sealing System as used in thyroid surgery. The Ligasure system is a hand held surgical device that uses heat to seal blood vessels during surgery. It has been a tested and accepted technology in abdominal surgery and it is now being applied to surgery of the thyroid gland because it is faster than the traditional method of tying blood vessels that a surgeon must do manually. To remove the thyroid gland safely the surgeon must dissect the gland away from the recurrent laryngeal nerve which controls the vocal cords and patient's voice. Protecting this nerve is the key step in all thyroid surgery as its damage can permanently alter a patient's voice and even obstruct the airway. At this time the worldwide accepted rate of nerve injury is 2 in 100 patients. The hypothesis of this study is that the nerve injury rates for surgery using the Ligasure device are similar to that seen when surgeons manually tie blood vessels. The investigators protocol will evaluate the function of the recurrent laryngeal nerve after removing the thyroid gland using the Ligasure device in comparison to the traditional method where the surgeon manually ties blood vessels. In this study, for patients undergoing total thyroidectomy for a benign condition, each patient will be randomized to have one lobe of thyroid (left or right) removed using manual tying of blood vessels and the other side will have the surgeon use the Ligasure device to seal blood vessels. Every patient has a pre- and post-operative independent assessment of vocal cord function using nasopharyngoscopy to ensure that the vocal cords are working normally prior to surgery and also to document vocal cord dysfunction if there is an injury to the recurrent laryngeal nerve. The investigators intent is to show that the Ligasure system is a safe method to sealing vessels in thyroid surgery and that the thermal dispersion of this device does not pose a significant increase in risk to the recurrent laryngeal nerve

Condition or disease Intervention/treatment Phase
Multinodular Goitre Grave's Disease Thyroid Nodule Device: Ligasure Device Not Applicable

Detailed Description:

Diathermy is an accepted modality to aid surgery and maintain hemostasis and is used in all forms of surgery including head and neck, neurosurgery and general surgery. The Ligasure vessel sealing system uses heat energy and has been approved for use in many different types of surgery and has been tested and accepted for use in multiple countries, including Canada. What is being tested in this proposal is the application of this accepted technology to thyroid surgery. There has been one previous randomized trial examining the Ligasure device in thyroid surgery but this was designed to look at operative times and bleeding episodes in comparison to manually tying blood vessels. It has been proven that the Ligasure device makes operations quicker and is just as effective at sealing blood vessels as manual tying by the surgeon. However, in thyroid surgery injury to the recurrent laryngeal nerve is an important concern as the nerve is in close proximity to the gland. Damage to the nerve could temporarily or permanently alter a patient's voice making it hoarse. In this study we examine if the heat generated by the device could damage the recurrent laryngeal nerve if it is held close enough for prolonged time periods. There are case reports that indicate that the Ligasure is safe but this study intends in a prospective, randomized manner to prove that the use of the Ligasure system does not affect nerve injury rates compared to a surgeon manually tying blood vessels during thyroid surgery.

Our hypothesis is that the use of the Ligasure vessel sealing system in thyroid surgery is as safe as the traditional manual tying of blood vessels by the surgeon in terms of injury to the recurrent laryngeal nerve.

We propose a randomized, prospective equivalence trail to compare recurrent laryngeal nerve injury rates with the use of the Ligasure device or manually tying blood vessels. The thyroid gland has two lobes, a left and a right, and under each lobe there is the recurrent laryngeal nerve (thus two per patient). With the traditional manual tying of vessels, approximately 2% of patients will have altered function in one of the recurrent laryngeal nerve, and we expect that the rates of altered function in the Ligasure patient cohort to be the same. To prove this we will enroll patients with benign thyroid disease, including multinodular goitre, Grave's disease, thyroid nodule or thyroiditis, having total thyroidectomy. Excluded are patients under 18 and those with known cancer as well as those undergoing reoperative surgery or those with known recurrent laryngeal nerve dysfunction. The patients will be randomized by computer to have dissection of the thyroid gland on one side (left or right) done with the traditional manual tying method and the other side will be done with the surgeon using the hand-held Ligasure device. The randomization process uses a random number generator to assign the patient a number as they are booked for the operating theatre. This process is independent of the surgeon such that they do not know the side to use the Ligasure until the day of the operation. After surgery an independent assessment of the vocal cords with nasopharyngoscopy is done on both the left and right side within 6 weeks of surgery by an otolaryngologist that is blinded to the surgical technique. This allows us to determine if either the left or right recurrent laryngeal nerve has been injured. If there is an injury it will be linked to whether the surgeon manually tied the vessels on that side or if they used the Ligasure device. Sample size calculations for this equivalence trial were based on Blackwelder (Controlled Clinical Trials 1982;3:345-353) which outline that to detect a 5% difference in injury rates, set at 2 in 100, between the Ligasure and traditional techniques we will need to complete dissections on 96 patients (each patient has one side Ligasure and one side manual tying).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 96 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery
Study Start Date : April 2010
Actual Primary Completion Date : September 2012
Actual Study Completion Date : December 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Thyroid Diseases

Arm Intervention/treatment
Active Comparator: Ligasure device Device: Ligasure Device
Ligasure device used to seal blood vessels during left or right side of a total thyroidectomy. Traditional method of hand ties/clips on contralateral side.

No Intervention: Hand ties

Primary Outcome Measures :
  1. recurrent laryngeal nerve injury [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • multinodular goiter
  • Grave's disease
  • thyroid nodule

Exclusion Criteria:

  • thyroid carcinoma
  • reoperative surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01163565

Layout table for location information
Canada, Alberta
Walter C Mackenzie Health Sciences Centre
Edmonton, Alberta, Canada, T6G 2B6
Sponsors and Collaborators
University of Alberta
Medtronic - MITG
Layout table for additonal information
Responsible Party: Todd McMullen, Associate Professor, University of Alberta Identifier: NCT01163565    
Other Study ID Numbers: Pro00004394
First Posted: July 15, 2010    Key Record Dates
Last Update Posted: December 3, 2014
Last Verified: December 2014
Keywords provided by Todd McMullen, University of Alberta:
Additional relevant MeSH terms:
Layout table for MeSH terms
Thyroid Nodule
Graves Disease
Thyroid Diseases
Endocrine System Diseases
Thyroid Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Head and Neck Neoplasms
Orbital Diseases
Eye Diseases
Autoimmune Diseases
Immune System Diseases